Healthcare AI startup Qritive bags US$7.5m funding for new markets expansion
Add BT as a preferred sourceJanice Tan
SINGAPORE-headquartered healthcare AI startup Qritive has raised US$7.5 million in a funding round led by MassMutal Ventures, supported by Enterprise Singapore’s investment arm Seeds Capital, and Exfinity Venture Partners.
The new capital will be used to drive geographical expansion, expand product portfolio and support regulatory clearances.
Founded in 2017 with operations in San Diego in the US and Pune in India, Qritive is an AI (artificial intelligence) solution developer that aims to advance digital pathology for cancer diagnosis, enhance imaging accuracy and improve health outcomes.
Its Pantheon digital pathology platform comprises tools for aspects including case management, reporting as well as slide viewing and analysis.
According to Qritive, its goal is to create an open-pathology environment as well as help make cancer diagnosis fast, accurate and affordable.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
ComfortDelGro’s Zig to buy S$10 million worth of BYD cars for private-hire fleet
Singapore telco price war squeezes earnings, strengthens case for StarHub-M1 deal, say analysts
Sats slides 13.6% as investors dump shares on profit-margin squeeze
When every phone becomes a satellite phone, what happens to Asia’s telcos?
